It's a "gateway to embryo editing to do enhancements." The post Scientists Concerned Latest Gene Editing of Human Embryos ...

A preprint describing genetically edited human embryos is raising concerns among scientists that the U.S. is becoming more ...

The new experiment from Egli and his colleagues represent the first time this technique has been used to edit embryonic cells ...

Researchers relied on a newer gene-editing technique that may make it possible to engineer embryos, a prospect that has long ...

In 2020, Jennifer Doudna won the Nobel Prize in chemistry for her work on the CRISPR-Cas9 gene-editing technology that allows ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...

The future of medicine is already here. Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling condition has succeeded in a Phase 3 trial ...

A DNA-guided CRISPR platform could make RNA detection and control more stable, scalable, and precise, opening new routes for diagnostics, transcriptome engineering, and future therapeutic research.

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

I hate to break this to you, but every child is a genetic experiment – and nature doesn’t care if things go wrong. Our genomes are awful messes created by conflicting evolutionary forces, and every ...